GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Other Operating Expense

Jianmin Pharmaceutical Group Co (SHSE:600976) Other Operating Expense : ¥306 Mil (TTM As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Other Operating Expense?

Jianmin Pharmaceutical Group Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥3 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥306 Mil.

Jianmin Pharmaceutical Group Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-152 Mil) to Dec. 2024 (¥335 Mil) but then declined from Dec. 2024 (¥335 Mil) to Mar. 2025 (¥3 Mil).

Jianmin Pharmaceutical Group Co's annual Other Operating Expense increased from Dec. 2022 (¥206 Mil) to Dec. 2023 (¥288 Mil) and increased from Dec. 2023 (¥288 Mil) to Dec. 2024 (¥303 Mil).


Jianmin Pharmaceutical Group Co Other Operating Expense Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co Other Operating Expense Chart

Jianmin Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.84 205.25 206.41 288.35 303.12

Jianmin Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 120.09 -152.38 335.11 3.00

Jianmin Pharmaceutical Group Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥306 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jianmin Pharmaceutical Group Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Jianmin Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
Executives
Du Ming De Director
He Qin Director
Gao Kai senior management
Wang Jun senior management
Huang Zhi Jun senior management
Pei Xue Jun senior management
Bu Zhong Jiang Director
Cheng Chao Yang senior management
Xu Sheng senior management
Hu Zhen Bo senior management
Liu Qin Qiang Director
Xiong Fu Liang senior management
Liu Peng senior management

Jianmin Pharmaceutical Group Co Headlines

No Headlines